Current
$19.37B
5-Year Average
$13.68B
All-Time High
$37.31B
All-Time Low
$6.84B
Market cap daily chart for Viatris (VTRS)
Jun 16, 2021 – Jun 12, 2026 · 1,254 trading days
Market Cap growth chart for Viatris (VTRS) from 2004 to 2026
Latest: +32.9%
Market Cap history table for Viatris (VTRS) from 2004 to 2026
| 2026 | $19.37B | +32.9% | +$4.79B | ||
| 2025 | $14.58B | -1.9% | −$281.37M | ||
| 2024 | $14.86B | +13.7% | +$1.79B | ||
| 2023 | $13.07B | -3.5% | −$478.94M | ||
| 2022 | $13.55B | -17.2% | −$2.81B | ||
| 2021 | $16.36B | +45.2% | +$5.09B | ||
| 2020 | $11.27B | +8.5% | +$884.84M | ||
| 2019 | $10.38B | -26.3% | −$3.70B | ||
| 2018 | $14.08B | -38.0% | −$8.62B | ||
| 2017 | $22.71B | +14.4% | +$2.85B | ||
| 2016 | $19.86B | -26.9% | −$7.31B | ||
| 2015 | $27.17B | +19.9% | +$4.51B | ||
| 2014 | $22.66B | +33.9% | +$5.73B | ||
| 2013 | $16.93B | +46.7% | +$5.39B | ||
| 2012 | $11.54B | +22.5% | +$2.12B | ||
| 2011 | $9.42B | +35.5% | +$2.46B | ||
| 2010 | $6.95B | +22.9% | +$1.29B | ||
| 2009 | $5.66B | +87.9% | +$2.65B | ||
| 2008 | $3.01B | -16.7% | −$605.41M | ||
| 2007 | $3.62B | -34.0% | −$1.86B | ||
| 2006 | $5.48B | +13.0% | +$631.93M | ||
| 2005 | $4.85B | -22.8% | −$1.43B | ||
| 2004 | $6.28B | — | — |
- 2026$19.37B+32.9%
- 2025$14.58B-1.9%
- 2024$14.86B+13.7%
- 2023$13.07B-3.5%
- 2022$13.55B-17.2%
- 2021$16.36B+45.2%
- 2020$11.27B+8.5%
- 2019$10.38B-26.3%
- 2018$14.08B-38.0%
- 2017$22.71B+14.4%
- 2016$19.86B-26.9%
- 2015$27.17B+19.9%
- 2014$22.66B+33.9%
- 2013$16.93B+46.7%
- 2012$11.54B+22.5%
- 2011$9.42B+35.5%
- 2010$6.95B+22.9%
- 2009$5.66B+87.9%
- 2008$3.01B-16.7%
- 2007$3.62B-34.0%
- 2006$5.48B+13.0%
- 2005$4.85B-22.8%
- 2004$6.28B—
Market Cap values are taken from Viatris's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at Viatris (VTRS)
According to Viatris's latest reported financial statements, the company's latest reported market cap is $15.88B. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2026, Viatris (VTRS) market cap totalled $19.37B – surged 32.9% year-over-year.
Over 2021–2026 (5 years), Viatris market cap expanded at a +3.4% compound annual rate, with mixed annual results across the window.
Viatris market cap peaked at $27.17B in 2015; the latest annual figure is $19.37B in 2026 (28.7% below peak).
The record annual market cap stands at $27.17B, reached in 2015; the historical low of $3.01B was recorded in 2008.
Viatris Market Cap by Year
Viatris Market Cap 2026: $19.37B
In 2026, Viatris reported market cap of $19.37B, surged 32.9% from 2025.
Viatris Market Cap 2025: $14.58B
Viatris market cap in 2025 was $14.58B, edged down 1.9% below 2024.
Viatris Market Cap 2024: $14.86B
2024's market cap for Viatris came in at $14.86B, grew 13.7% from 2023.
Viatris Market Cap 2023: $13.07B
Viatris posted market cap of $13.07B in 2023, edged down 3.5% below 2022.
Viatris Market Cap 2022: $13.55B
Viatris market cap in 2022 was $13.55B.
See more financial history for Viatris (VTRS).
Sector peers by Market Cap
Healthcare peers of Viatris (VTRS), ranked by their latest market cap
| $1.07T | |
| $579.83B | |
| $391.50B | |
| $371.00B | |
| $294.03B | |
| $277.22B | |
| $194.99B | |
| $191.70B |
- $1.07T
- $579.83B
- $391.50B
- $371.00B
- $294.03B
- $277.22B
- $194.99B
- $191.70B
Frequently asked questions
Viatris (VTRS) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation